152 related articles for article (PubMed ID: 27997622)
21. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
Warris LT; van den Akker EL; Aarsen FK; Bierings MB; van den Bos C; Tissing WJ; Sassen SD; Veening MA; Zwaan CM; Pieters R; van den Heuvel-Eibrink MM
Psychoneuroendocrinology; 2016 Oct; 72():190-5. PubMed ID: 27448086
[TBL] [Abstract][Full Text] [Related]
22. Hypocretin/orexin antagonism enhances sleep-related adenosine and GABA neurotransmission in rat basal forebrain.
Vazquez-DeRose J; Schwartz MD; Nguyen AT; Warrier DR; Gulati S; Mathew TK; Neylan TC; Kilduff TS
Brain Struct Funct; 2016 Mar; 221(2):923-40. PubMed ID: 25431268
[TBL] [Abstract][Full Text] [Related]
23. The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
Gao F; Liu T; Tuo M; Chi S
Neurosci Lett; 2021 Nov; 765():136247. PubMed ID: 34530113
[TBL] [Abstract][Full Text] [Related]
24. Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect.
Liu ZW; Gao XB
J Neurophysiol; 2007 Jan; 97(1):837-48. PubMed ID: 17093123
[TBL] [Abstract][Full Text] [Related]
25. The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems.
Parks GS; Warrier DR; Dittrich L; Schwartz MD; Palmerston JB; Neylan TC; Morairty SR; Kilduff TS
Neuropsychopharmacology; 2016 Mar; 41(4):1144-55. PubMed ID: 26289145
[TBL] [Abstract][Full Text] [Related]
26. Quinolinate induces selective loss of melanin-concentrating hormone neurons, rather than orexin neurons, in the hypothalamus of mice and young rats.
Obukuro K; Takigawa M; Hisatsune A; Isohama Y; Katsuki H
Neuroscience; 2010 Sep; 170(1):298-307. PubMed ID: 20620197
[TBL] [Abstract][Full Text] [Related]
27. Alterations of orexinergic and melanin-concentrating hormone neurons in experimental sleeping sickness.
Palomba M; Seke-Etet PF; Laperchia C; Tiberio L; Xu YZ; Colavito V; Grassi-Zucconi G; Bentivoglio M
Neuroscience; 2015 Apr; 290():185-95. PubMed ID: 25595977
[TBL] [Abstract][Full Text] [Related]
28. Orexins/hypocretins modulate the activity of NPY-positive and -negative neurons in the rat intergeniculate leaflet via OX1 and OX2 receptors.
Palus K; Chrobok L; Lewandowski MH
Neuroscience; 2015 Aug; 300():370-80. PubMed ID: 26022361
[TBL] [Abstract][Full Text] [Related]
29. Exploring the Role of Orexinergic Neurons in Parkinson's Disease.
Kumar S; Behl T; Sehgal A; Singh S; Sharma N; Bhatia S; Al-Harassi A; Abdel-Daim MM; Bungau S
Neurotox Res; 2021 Dec; 39(6):2141-2153. PubMed ID: 34495449
[TBL] [Abstract][Full Text] [Related]
30. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
Hoyer D; Jacobson LH
Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
[TBL] [Abstract][Full Text] [Related]
31. Orexin A and B in vitro modify orexins receptors expression and gonadotropins secretion of anterior pituitary cells of proestrous rats.
Cataldi NI; Lux Lantos VA; Libertun C
Regul Pept; 2014 Jan; 188():25-30. PubMed ID: 24333629
[TBL] [Abstract][Full Text] [Related]
32. Orexin-A and respiration in a rat model of smoke-induced chronic obstructive pulmonary disease.
Liu ZB; Song NN; Geng WY; Jin WZ; Li L; Cao YX; Qian Y; Zhu DN; Shen LL
Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):963-8. PubMed ID: 20528981
[TBL] [Abstract][Full Text] [Related]
33. Orexin A-mediated AKT signaling in the dentate gyrus contributes to the acquisition, expression and reinstatement of morphine-induced conditioned place preference.
Guo SJ; Cui Y; Huang ZZ; Liu H; Zhang XQ; Jiang JX; Xin WJ
Addict Biol; 2016 May; 21(3):547-59. PubMed ID: 25757577
[TBL] [Abstract][Full Text] [Related]
34. Plasma concentrations of orexins in children.
Tomasik PJ; Spodaryk M; Sztefko K
Ann Nutr Metab; 2004; 48(4):215-20. PubMed ID: 15331880
[TBL] [Abstract][Full Text] [Related]
35. Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats.
Kajiyama S; Kawamoto M; Shiraishi S; Gaus S; Matsunaga A; Suyama H; Yuge O
Brain Res; 2005 May; 1044(1):76-86. PubMed ID: 15862792
[TBL] [Abstract][Full Text] [Related]
36. Decreased orexin (hypocretin) immunoreactivity in the hypothalamus and pontine nuclei in sudden infant death syndrome.
Hunt NJ; Waters KA; Rodriguez ML; Machaalani R
Acta Neuropathol; 2015 Aug; 130(2):185-98. PubMed ID: 25953524
[TBL] [Abstract][Full Text] [Related]
37. Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice.
Liu M; Thankachan S; Kaur S; Begum S; Blanco-Centurion C; Sakurai T; Yanagisawa M; Neve R; Shiromani PJ
Eur J Neurosci; 2008 Oct; 28(7):1382-93. PubMed ID: 18973565
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of neural activity depletes orexin from rat hypothalamic slice culture.
Michinaga S; Hisatsune A; Isohama Y; Katsuki H
J Neurosci Res; 2010 Jan; 88(1):214-21. PubMed ID: 19610104
[TBL] [Abstract][Full Text] [Related]
39. Orexin-A facilitates emergence of the rat from isoflurane anesthesia via mediation of the basal forebrain.
Zhang LN; Yang C; Ouyang PR; Zhang ZC; Ran MZ; Tong L; Dong HL; Liu Y
Neuropeptides; 2016 Aug; 58():7-14. PubMed ID: 26919917
[TBL] [Abstract][Full Text] [Related]
40. Increased orexin expression promotes sleep/wake disturbances in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Liu R; Sheng ZF; Cai B; Zhang YH; Fan DS
Chin Med J (Engl); 2015 Jan; 128(2):239-44. PubMed ID: 25591569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
